Capricor Therapeutics
CAPR
#6981
Rank
โ‚น35.37 B
Marketcap
โ‚น774.47
Share price
-2.27%
Change (1 day)
36.61%
Change (1 year)

Capricor Therapeutics (CAPR) - P/B ratio

P/B ratio as of April 2025 : 2.78

According to Capricor Therapeutics 's latest financial reports the company has a price-to-book ratio of 18.1716.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Capricor Therapeutics - P/B ratio (from 2002 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-314.40-33.94%
2023-12-316.66-19.41%
2022-12-318.27266.48%
2021-12-312.26-9.3%
2020-12-312.49154.22%
2019-12-310.9783-64.91%
2018-12-312.79-22.94%
2017-12-313.62-125.45%
2016-12-31-14.2-70.64%
2015-12-31-48.4589.23%
2014-12-31-7.03-90.11%
2013-12-31-71.0-16674.27%
2012-12-310.4285-98.36%
2011-12-3126.1215.08%
2010-12-318.27-24.77%
2009-12-3111.0173.25%
2008-12-314.02-53.88%
2007-12-318.72-138.92%
2006-12-31-22.4-64.56%
2005-12-31-63.2-24.3%
2004-12-31-83.5-11.76%
2003-12-31-94.6-78.04%
2002-12-31-431

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
-32.8-1,277.92%๐Ÿ‡บ๐Ÿ‡ธ USA
-2.15-177.39%๐Ÿ‡บ๐Ÿ‡ธ USA
5.22 87.60%๐Ÿ‡บ๐Ÿ‡ธ USA
3.69 32.52%๐Ÿ‡บ๐Ÿ‡ธ USA
1.39-50.07%๐Ÿ‡บ๐Ÿ‡ธ USA
5.64 102.69%๐Ÿ‡บ๐Ÿ‡ธ USA